Abstract:Protein kinases are attractive therapeutic targets because their dysregulation underlies many diseases, including cancer. The high conservation of the kinase domain and the evolution of drug resistance, however, pose major challenges to the development of specific kinase inhibitors. We recently discovered selective Src kinase inhibitors from a DNA-templated macrocycle library. Here, we reveal the structural basis for how these inhibitors retain activity against a disease-relevant, drug-resistant kinase mutant,… Show more
“…The two structures reported here represent the first reported X-ray crystal structures with pNO 2 F incorporated into a protein structure using the amber codon-suppression technology. Previous structures containing the pNO 2 F residue contained pNO 2 F on a synthesized short peptide fragment (4-8 residues; Rose et al, 1996;Lizak et al, 2011;Aleem et al, 2016;Napió rkowska et al, 2017) or a semi-synthetic protein in which the pNO 2 F was synthesized in a peptide that was later ligated to an expressed protein fragment (Baril et al, 2017). The Asp133pNO 2 F sfGFP and Asn149pNO 2 F sfGFP crystal structures illustrate clear density for the pNO 2 F residue at the specified position, indicating that pNO 2 F can be sitespecifically incorporated to produce a stable pNO 2 F group.…”
The X-ray crystal structures of two superfolder green fluorescent protein (sfGFP) constructs containing a genetically incorporated spectroscopic reporter unnatural amino acid, 4-nitro-l-phenylalanine (pNO 2 F), at two unique sites in the protein have been determined. Amber codon-suppression methodology was used to site-specifically incorporate pNO 2 F at a solvent-accessible (Asp133) and a partially buried (Asn149) site in sfGFP. The Asp133pNO 2 F sfGFP construct crystallized with two molecules per asymmetric unit in space group P3 2 21 and the crystal structure was refined to 2.05 Å resolution. Crystals of Asn149pNO 2 F sfGFP contained one molecule of sfGFP per asymmetric unit in space group P4 1 22 and the structure was refined to 1.60 Å resolution. The alignment of Asp133pNO 2 F or Asn149pNO 2 F sfGFP with wild-type sfGFP resulted in small root-mean-square deviations, illustrating that these residues do not significantly alter the protein structure and supporting the use of pNO 2 F as an effective spectroscopic reporter of local protein structure and dynamics.
“…The two structures reported here represent the first reported X-ray crystal structures with pNO 2 F incorporated into a protein structure using the amber codon-suppression technology. Previous structures containing the pNO 2 F residue contained pNO 2 F on a synthesized short peptide fragment (4-8 residues; Rose et al, 1996;Lizak et al, 2011;Aleem et al, 2016;Napió rkowska et al, 2017) or a semi-synthetic protein in which the pNO 2 F was synthesized in a peptide that was later ligated to an expressed protein fragment (Baril et al, 2017). The Asp133pNO 2 F sfGFP and Asn149pNO 2 F sfGFP crystal structures illustrate clear density for the pNO 2 F residue at the specified position, indicating that pNO 2 F can be sitespecifically incorporated to produce a stable pNO 2 F group.…”
The X-ray crystal structures of two superfolder green fluorescent protein (sfGFP) constructs containing a genetically incorporated spectroscopic reporter unnatural amino acid, 4-nitro-l-phenylalanine (pNO 2 F), at two unique sites in the protein have been determined. Amber codon-suppression methodology was used to site-specifically incorporate pNO 2 F at a solvent-accessible (Asp133) and a partially buried (Asn149) site in sfGFP. The Asp133pNO 2 F sfGFP construct crystallized with two molecules per asymmetric unit in space group P3 2 21 and the crystal structure was refined to 2.05 Å resolution. Crystals of Asn149pNO 2 F sfGFP contained one molecule of sfGFP per asymmetric unit in space group P4 1 22 and the structure was refined to 1.60 Å resolution. The alignment of Asp133pNO 2 F or Asn149pNO 2 F sfGFP with wild-type sfGFP resulted in small root-mean-square deviations, illustrating that these residues do not significantly alter the protein structure and supporting the use of pNO 2 F as an effective spectroscopic reporter of local protein structure and dynamics.
“…Despite its modest size compared with subsequent industrial DNA-encoded libraries 9, 11, 42 , this initial library was of sufficient quality and diversity to serve as a source of potent and selective inhibitors of proteins including kinases and insulin-degrading enzyme (IDE) protease, ultimately leading to biological discoveries and the validation in vivo of new targets for therapeutic intervention. 43–46 …”
DNA-encoded libraries have emerged as a widely used resource for discovery of bioactive small molecules and offer substantial advantages compared to conventional small-molecule libraries. Here we developed and streamlined multiple fundamental aspects of DNA-encoded and DNA-templated library synthesis methodology, including computational identification and experimental validation of a 20×20×20×80 set of orthogonal codons, chemical and computational tools for enhancing the structural diversity and drug-likeness of library members, a highly efficient polymerase-mediated template library assembly strategy, and library isolation and purification methods. We integrated these improved methods to produce a second-generation DNA-templated library of 256,000 small-molecule macrocycles with improved drug-like physical properties. In vitro selection of this library for insulin-degrading enzyme (IDE) affinity resulted in novel IDE inhibitors including one of unusual potency and novel macrocycle stereochemistry (IC50 = 40 nM). Collectively, these developments enable DNA-templated small-molecule libraries to serve as more powerful, accessible, streamlined, and cost-effective tools for bioactive small-molecule discovery.
“…The MDA-MB-231 cells rely on Src signalling for cell migration and metastasis ( Figure 4 b). ( 44 , 45 ) We observed that 4 inhibits the autophosphorylation of Src in the cell ( Figure 4 d) and significantly impaired the wound healing rates (IC 10 and IC 50 dose) ( Figure S8b-c ). The migration process involves the TNF-α induced activation of Src signalling cascade and translocation of ERK1/2 to the nucleus.…”
Hck, a Src family non-receptor tyrosine kinase (SFK), has recently been established as an attractive pharmacological target to improve pulmonary function in COVID-19 patients. Hck inhibitors are also well known for their regulatory role in various malignancies and autoimmune diseases. Curcumin has been previously identified as an excellent DYRK-2 inhibitor, but curcumin's fate is tainted by its instability in the cellular environment. Besides, small molecules targeting the inactive states of a kinase are desirable to reduce promiscuity. Here, we show that functionalization of the 4-arylidene position of the fluorescent curcumin scaffold with an aryl nitrogen mustard provides a stable Hck inhibitor (K
d
= 50 ± 10 nM). The mustard curcumin derivative preferentially interacts with the inactive conformation of Hck, similar to type-II kinase inhibitors that are less promiscuous. Moreover, the lead compound showed no inhibitory effect on three other kinases (DYRK2, Src and Abl). We demonstrate that the cytotoxicity may be mediated via inhibition of the SFK signalling pathway in triple-negative breast cancer and murine macrophage cells. Our data suggest that curcumin is a modifiable fluorescent scaffold to develop selective kinase inhibitors by remodelling its target affinity and cellular stability.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.